Extended-spectrum beta-lactamase-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in diabetic foot infections
<b>Aims:</b> Diabetic foot lesions are a major medical, social, and economic problem and are the leading cause of hospitalization for patients with diabetes, worldwide. ESBL-producing bacteria may not be detectable by routine disc diffusion susceptibility test, leading to inappropriate...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2008-07-01
|
Series: | Indian Journal of Pathology and Microbiology |
Subjects: | |
Online Access: | http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2008;volume=51;issue=3;spage=370;epage=372;aulast=Varaiya |
_version_ | 1818617936090234880 |
---|---|
author | Varaiya Ami Dogra Jyotsana Kulkarni Manasi Bhalekar Pallavi |
author_facet | Varaiya Ami Dogra Jyotsana Kulkarni Manasi Bhalekar Pallavi |
author_sort | Varaiya Ami |
collection | DOAJ |
description | <b>Aims:</b> Diabetic foot lesions are a major medical, social, and economic problem and are the leading cause of hospitalization for patients with diabetes, worldwide. ESBL-producing bacteria may not be detectable by routine disc diffusion susceptibility test, leading to inappropriate use of antibiotics and treatment failure. There is not much information on ESBL-producing organisms causing diabetic foot infection. An attempt was therefore made to study the ESBL-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in diabetic foot patients with type 2 diabetes mellitus. <b> Materials and Methods:</b> A total of 134 isolates of <i>E. coli</i> and <i>K. pneumoniae</i> were obtained from tissue, pus swab, and wound swab samples from diabetic foot ulcers submitted for routine microbiological analysis during the period January to December 2005 from patients with diabetic foot infections who had type 2 diabetes mellitus, attending S. L. Raheja Hospital. The above isolates were tested for antimicrobial susceptibility by disc diffusion technique according to clinical and laboratory standards institute (CLSI) guidelines. The screening for ESBL production was done by phenotypic confirmatory test using ceftazidime disc in the presence and absence of clavulanic acid as recommended by CLSI. <b> Results:</b> Among the 134 isolates, 54 (40.29%) were <i>E. coli</i> and 80 (59.70%) were <i>K. pneumoniae;</i> among which, ESBL production was detected in 31 (23.13%) isolates. Of these 31, 15 (48.38%) were <i>E. coli</i> and 16 (51.61%) were <i>K. pneumoniae</i>. All the ESBL-producing isolates were found to be 100% sensitive to carbapenem (imipenem and meropenem). Mortality was found to be 3.22%, the cause of death being septicemia leading to multiple organ failure. <b> Conclusions:</b> The prevalence of ESBLs among members of <i>Enterobacteriaceae</i> constitutes a serious threat to the current beta-lactam therapy, leading to treatment failure and consequent escalation of costs. There is an urgent need to emphasize rational use of drugs to minimize the misuse of available antimicrobials. |
first_indexed | 2024-12-16T17:13:36Z |
format | Article |
id | doaj.art-b8d3437cbe324ba9abe8e6ce87d9a0a7 |
institution | Directory Open Access Journal |
issn | 0377-4929 |
language | English |
last_indexed | 2024-12-16T17:13:36Z |
publishDate | 2008-07-01 |
publisher | Wolters Kluwer Medknow Publications |
record_format | Article |
series | Indian Journal of Pathology and Microbiology |
spelling | doaj.art-b8d3437cbe324ba9abe8e6ce87d9a0a72022-12-21T22:23:21ZengWolters Kluwer Medknow PublicationsIndian Journal of Pathology and Microbiology0377-49292008-07-01513370372Extended-spectrum beta-lactamase-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in diabetic foot infectionsVaraiya AmiDogra JyotsanaKulkarni ManasiBhalekar Pallavi<b>Aims:</b> Diabetic foot lesions are a major medical, social, and economic problem and are the leading cause of hospitalization for patients with diabetes, worldwide. ESBL-producing bacteria may not be detectable by routine disc diffusion susceptibility test, leading to inappropriate use of antibiotics and treatment failure. There is not much information on ESBL-producing organisms causing diabetic foot infection. An attempt was therefore made to study the ESBL-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in diabetic foot patients with type 2 diabetes mellitus. <b> Materials and Methods:</b> A total of 134 isolates of <i>E. coli</i> and <i>K. pneumoniae</i> were obtained from tissue, pus swab, and wound swab samples from diabetic foot ulcers submitted for routine microbiological analysis during the period January to December 2005 from patients with diabetic foot infections who had type 2 diabetes mellitus, attending S. L. Raheja Hospital. The above isolates were tested for antimicrobial susceptibility by disc diffusion technique according to clinical and laboratory standards institute (CLSI) guidelines. The screening for ESBL production was done by phenotypic confirmatory test using ceftazidime disc in the presence and absence of clavulanic acid as recommended by CLSI. <b> Results:</b> Among the 134 isolates, 54 (40.29%) were <i>E. coli</i> and 80 (59.70%) were <i>K. pneumoniae;</i> among which, ESBL production was detected in 31 (23.13%) isolates. Of these 31, 15 (48.38%) were <i>E. coli</i> and 16 (51.61%) were <i>K. pneumoniae</i>. All the ESBL-producing isolates were found to be 100% sensitive to carbapenem (imipenem and meropenem). Mortality was found to be 3.22%, the cause of death being septicemia leading to multiple organ failure. <b> Conclusions:</b> The prevalence of ESBLs among members of <i>Enterobacteriaceae</i> constitutes a serious threat to the current beta-lactam therapy, leading to treatment failure and consequent escalation of costs. There is an urgent need to emphasize rational use of drugs to minimize the misuse of available antimicrobials.http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2008;volume=51;issue=3;spage=370;epage=372;aulast=Varaiya<i>Escherichia coli</i>extended-spectrum beta-lactamase<i>Klebsiella pneumoniae </i> |
spellingShingle | Varaiya Ami Dogra Jyotsana Kulkarni Manasi Bhalekar Pallavi Extended-spectrum beta-lactamase-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in diabetic foot infections Indian Journal of Pathology and Microbiology <i>Escherichia coli </i>extended-spectrum beta-lactamase <i>Klebsiella pneumoniae </i> |
title | Extended-spectrum beta-lactamase-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in diabetic foot infections |
title_full | Extended-spectrum beta-lactamase-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in diabetic foot infections |
title_fullStr | Extended-spectrum beta-lactamase-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in diabetic foot infections |
title_full_unstemmed | Extended-spectrum beta-lactamase-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in diabetic foot infections |
title_short | Extended-spectrum beta-lactamase-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in diabetic foot infections |
title_sort | extended spectrum beta lactamase producing i escherichia coli i and i klebsiella pneumoniae i in diabetic foot infections |
topic | <i>Escherichia coli </i>extended-spectrum beta-lactamase <i>Klebsiella pneumoniae </i> |
url | http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2008;volume=51;issue=3;spage=370;epage=372;aulast=Varaiya |
work_keys_str_mv | AT varaiyaami extendedspectrumbetalactamaseproducingiescherichiacoliiandiklebsiellapneumoniaeiindiabeticfootinfections AT dograjyotsana extendedspectrumbetalactamaseproducingiescherichiacoliiandiklebsiellapneumoniaeiindiabeticfootinfections AT kulkarnimanasi extendedspectrumbetalactamaseproducingiescherichiacoliiandiklebsiellapneumoniaeiindiabeticfootinfections AT bhalekarpallavi extendedspectrumbetalactamaseproducingiescherichiacoliiandiklebsiellapneumoniaeiindiabeticfootinfections |